← All stories
Health, Longevity & Biohacking

Pharmaceutical Transplant Drug Derived from Mycotoxin Reveals Immunosuppression Power of Mold

The Ultimate Human · Dr. John Kim: On Mold Toxicity, Mycotoxins, Heavy Metals, & Cellular Detox · June 9, 2026
Pharmaceutical Transplant Drug Derived from Mycotoxin Reveals Immunosuppression Power of Mold
The Ultimate Human
The Ultimate Human
Dr. John Kim: On Mold Toxicity, Mycotoxins, Heavy Metals, & Cellular Detox
"There's a drug called mycophenolate. The brand name is called CellCept. They utilize a particular drug for kidney transplant patients so that you don't have an organ rejection. Well, that mycophenolate, that's the drug name, derived from mycophenolic acid, which is a mycotoxin itself. That's how powerful these mycotoxins are of causing immunosuppression."
Dr. Kim revealed that the immunosuppressant drug CellCept, commonly prescribed to prevent organ transplant rejection, is derived from mycophenolic acid—a mycotoxin produced by mold. This admission demonstrates the pharmaceutical industry's awareness of mycotoxins' profound immunosuppressive effects, while such toxins are simultaneously dismissed as insignificant environmental exposures by mainstream medicine. The revelation adds credibility to claims that chronic mold exposure causes serious immune dysfunction.

About this episode

On this episode of The Ultimate Human Podcast, host Gary Brecka sat down with Dr. John Kim, a PharmD specializing in cellular health, mold toxicity, and drug-induced mitochondrial dysfunction, for an in-depth discussion on how chronic low-grade infections—particularly mold, mycotoxins, heavy metals, and tick-borne illnesses—cause systemic disease that conventional medicine routinely misses. The conversation opened with Dr. Kim's origin story: at age 33, he suffered a widowmaker heart attack with 85% LAD blockage, only to discover the root cause was not cholesterol but a constellation of mold toxicity, Bartonella infection from tick exposure, Epstein-Barr virus, and mercury poisoning. This personal health crisis catalyzed his 2-year detox journey and his development of the ENCOR Method—a clinical framework addressing Environment, Nervous system regulation, Cellular integrity, Optimization of detox pathways, and Rebalancing the microbiome. Brecka and Dr. Kim dissected why most practitioners skip straight to gut protocols without first addressing biofilms, mitochondrial dysfunction, and environmental toxins like non-native EMF and blue light, which Dr. Kim argues disrupt magnesium absorption and methylation regardless of supplementation. The episode featured striking clinical revelations, including that the immunosuppressant drug CellCept is derived from a mold-produced mycotoxin, and that deuterium-depleted water has reversed type 2 diabetes in six weeks in published studies. Dr. Kim walked through his testing protocols—real-time urine mycotoxin panels, Vibrant Gut Zoomer stool tests, and provoked mycotoxin testing using molybdenum and bioflavonoids—and detailed his treatment stack: phosphatidylcholine IV therapy, butyrate for DNA repair, biofilm busters like N-acetylcysteine, and spore-based probiotics. He emphasized that detox must be slow and sequential to avoid overwhelming the sympathetic nervous system, and shared a case study of a grieving mother whose resting heart rate dropped from 90 to 60 bpm in six weeks using HeartMath coherence breathing. The episode concluded with Brecka crediting Dr. Kim for filling gaps in his own methylation-focused practice and teasing a future deep-dive episode on drug-induced mitochondrial dysfunction.

Key takeaways

More stories More from The Ultimate Human